Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
VENCLEXTA® (venetoclax tablets): CLL/SLL and AML Treatment
Discover VENCLEXTA® (venetoclax tablets): An oral therapy to help you fight certain blood cancers. See full Prescribing and Safety information.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for venclexta.com: 3.162.125.12, 3.162.125.15, 3.162.125.29, 3.162.125.64. Moreover, DNS used with this website include ns11.constellix.com, ns21.constellix.com, ns31.constellix.com, ns41.constellix.net, ns51.constellix.net, ns61.constellix.net. Subnet identifier ranges from 3.160.0.0 to 3.163.255.255. Classless Inter-Domain Routing (CIDR) is 3.160.0.0/14. ARIN net type is Reallocated.
Daily Visitors
Last scanned
Domain Age
Global Rank
ns11.constellix.com
ns21.constellix.com
ns31.constellix.com
ns41.constellix.net
ns51.constellix.net
ns61.constellix.net
{{value}}
2014-12-17
2024-12-17
MarkMonitor Inc.
{{value}}
The registrar of venclexta.com is MarkMonitor Inc. and the name expires on 2024-12-17. According to open source data, you can reach the owner at internetnameregistrar@abbvie.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
534
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
534